| abstract |
This invention is related to the field of medicinal chemistry, the invention relates to a new class of small molecules that have a benzimidazole or imidazopyridine structure that function as DYRKIA inhibitors, and their use as therapeutic products for the treatment of Alzheimer's disease. , Down syndrome, glioblastoma, autoimmune diseases, inflammatory disorders (for example, airway inflammation) and other diseases. |